The Importance of Treating OSD and Lid Margin Disease Preoperatively

• April 11, 2026

Creation and assessment of a predictive model for dry eye disease risk in myopic pediatric patients

• by Bingqing Li, Jie Wen, Jie Qin, Ran Gao, Hanruo Liu, Fengju Zhang

• April 28, 2026

Impact of extended reality (XR) simulation on ophthalmology training outcomes: an updated systematic review and meta-analysis

• by Yuxi Jiang, Shengfang Ge, Bilian Ke

• May 1, 2026

IL-6 Inhibitor Vamikibart Shows Efficacy Signals in DME Trial

At ARVO 2026, Arshad M. Khanani, MD, MA, FASRS, presented phase 2 data on vamikibart, an IL-6 inhibitor, in diabetic macular edema.

• by Arshad M. Khanani, MD, MA, FASRS, Arshad M. Khanani, MD, MA, FASRS

• May 1, 2026

• 4 min